drugset / Trial / NCT01535079

Acute Sore Throat Pain Study

NCT01535079

Phase 2 Completed 186 enrolled Pierre Fabre Laboratories
RandomizedParallel-groupTriple-blindTreatment

Summary

"Sore throat is one of the most common complaints encountered in clinical practice. And in 65% of cases, the infection is thought to be viral in nature. The aim of this study is to evaluate the analgesic profile of 3 Ibuprofen lozenges after single administration in acute sore throat pain."

Timeline

Start
2012-02
Primary completion
2012-11
Completion
2012-11

Drugs

EvaluationDrugModalityDoseRoute
Subject Ibuprofen Small molecule 15 mg
Subject Ibuprofen Small molecule 25 mg
Subject Ibuprofen Small molecule 35 mg
Subject Strefen Unknown

Indications